Professional Resources

  • Celgene-Sponsored Clinical Studies Search for information about Celgene-Sponsored Clinical Studies based on disease state.
  • INVESTIGATOR-INITIATED TRIALS Submit a request for a Clinical Investigator-initiated Trial
  • Celgene Educational Grants The Educational Grants Program awards high quality, independent educational programs and materials, which demonstrate the potential to improve patient care and health outcomes.
  • Celgene Research & Development View our pipeline and information about our medicines in development.
  • Bolder Science is a destination to get fast, easy and relevant scientific information and unbiased clinical trial searches. It also provides details on our scientific programs and research.
  • This site provides additional information about clinical studies including a study description, entry criteria, contact information and facility names where they are being conducted
  • Celgene REMS Program To avoid embryo-fetal exposure, Risk Evaluation and Mitigation Strategy (REMS) programs are mandatory for the Celgene products THALOMID® (thalidomide), REVLIMID® (lenalidomide) and POMALYST® (pomalidomide). The THALOMID REMS® program (formerly known as the S.T.E.P.S.® program), REVLIMID REMS® program (formerly known as the RevAssist® program) and POMALYST REMS® program require prescribers and pharmacists to be certified and patients to enroll and comply with all of the requirements for each program.

Speak to A Medical
Information Professional


Request A Call Back

Have a Medical Information Professional contact you back

Hours available:
8:30AM-5:00PM EST Mon-Fri

Important Notice

This site is for informational purposes only and is intended to address unsolicited medical questions by healthcare professionals based in the United States. This resource may contain medical and scientific information about Celgene products and/or uses that have not been approved by the United States Food and Drug Administration.

If you are not a healthcare professional, please discuss any questions you have regarding your health or treatment with your physician, pharmacist, or nurse.

Celgene is now part of Bristol-Myers Squibb. For Zeposia® (ozanimod) medical information inquiries please call 877-417-1523, or visit For all other product medical information inquiries please continue to the website.

By clicking continue, you are acknowledging that you are a US-based healthcare professional.


If you are not a US-based healthcare professional


You are now leaving

a website provided by Celgene. Clicking ‘Continue’ will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit.

To request information about a Celgene Investigational Compound, please contact a Medical Information Professional at (888)771-0141 or learn more at Celgene R&D or

Request Call Back

  • Date Format: MM slash DD slash YYYY
  • (Hours of operation: 8:30AM – 5:00PM EST, Mon-Fri, Excluding Celgene Holidays)

  • to

Celgene is now part of Bristol-Myers Squibb.

To request information about ZEPOSIA® (ozanimod), please contact a Medical Information Professional at (877)-417-1523 or learn more at